Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation

Bateman, Nicholas

52 - Featured Poster
Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation

Sunday, March 23, 2014: 7:07 AM

Room 13-16 (Tampa Convention Center)

N. W. Bateman¹, P. N. Teng¹, K. A. Conrads¹, C. A. Hamilton², G. L. Maxwell³, C. J. Bakkenist⁴ and T. P. Conrads¹
¹Gynecologic Cancer Center of Excellence, Annandale, VA, ²Walter Reed National Military Medical Center, Bethesda, MD, ³Inova Fairfax Hospital, Falls Church, VA, ⁴University of Pittsburgh, Pittsburgh, PA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

52 - Featured Poster
Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation

52 - Featured Poster Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation

52 - Featured Poster
Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation